Escalon Medical Share Holder Equity 2010-2024 | ESMC
Escalon Medical share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Escalon Medical Annual Share Holder Equity
(Millions of US $) |
| 2024 |
$2 |
| 2023 |
$2 |
| 2022 |
$1 |
| 2021 |
$1 |
| 2020 |
$2 |
| 2019 |
$2 |
| 2018 |
$2 |
| 2017 |
$1 |
| 2016 |
$2 |
| 2015 |
$3 |
| 2014 |
$3 |
| 2013 |
$4 |
| 2012 |
$1 |
| 2011 |
$6 |
| 2010 |
$12 |
| 2009 |
$12 |
Escalon Medical Quarterly Share Holder Equity
(Millions of US $) |
| 2024-12-31 |
$2 |
| 2024-09-30 |
$2 |
| 2024-06-30 |
$2 |
| 2024-03-31 |
$2 |
| 2023-12-31 |
$2 |
| 2023-09-30 |
$2 |
| 2023-06-30 |
$2 |
| 2023-03-31 |
$2 |
| 2022-12-31 |
$1 |
| 2022-09-30 |
$1 |
| 2022-06-30 |
$1 |
| 2022-03-31 |
$1 |
| 2021-12-31 |
$2 |
| 2021-09-30 |
$2 |
| 2021-06-30 |
$1 |
| 2021-03-31 |
$1 |
| 2020-12-31 |
$1 |
| 2020-09-30 |
$1 |
| 2020-06-30 |
$2 |
| 2020-03-31 |
$2 |
| 2019-12-31 |
$2 |
| 2019-09-30 |
$3 |
| 2019-06-30 |
$2 |
| 2019-03-31 |
$2 |
| 2018-12-31 |
$2 |
| 2018-09-30 |
$2 |
| 2018-06-30 |
$2 |
| 2018-03-31 |
$2 |
| 2017-12-31 |
$2 |
| 2017-09-30 |
$1 |
| 2017-06-30 |
$1 |
| 2017-03-31 |
$1 |
| 2016-12-31 |
$1 |
| 2016-09-30 |
$2 |
| 2016-06-30 |
$2 |
| 2016-03-31 |
$2 |
| 2015-12-31 |
$2 |
| 2015-09-30 |
$3 |
| 2015-06-30 |
$3 |
| 2015-03-31 |
$3 |
| 2014-12-31 |
$3 |
| 2014-09-30 |
$3 |
| 2014-06-30 |
$3 |
| 2014-03-31 |
$4 |
| 2013-12-31 |
$4 |
| 2013-09-30 |
$4 |
| 2013-06-30 |
$4 |
| 2013-03-31 |
$4 |
| 2012-12-31 |
$5 |
| 2012-09-30 |
$0 |
| 2012-06-30 |
$1 |
| 2012-03-31 |
$2 |
| 2011-12-31 |
$2 |
| 2011-09-30 |
$6 |
| 2011-06-30 |
$6 |
| 2011-03-31 |
$9 |
| 2010-12-31 |
$10 |
| 2010-09-30 |
$11 |
| 2010-06-30 |
$12 |
| 2010-03-31 |
$11 |
| 2009-12-31 |
$11 |
| 2009-09-30 |
$12 |
| 2009-06-30 |
$12 |
| 2009-03-31 |
$23 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.001B |
$0.012B |
|
Escalon Medical Corp. develops, markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access devices. The company utilizes strategic partnerships to help finance its development programs and is also seeking acquisitions to further diversify its product line to achieve critical mass in sales and take better advantage of the company's distribution capabilities.
|
